tegafur has been researched along with Carcinoma, Transitional Cell in 25 studies
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The safety of prolonged administration of UFT in which tegafur and uracil were mixed in a ratio of 1:4 in molar fraction was studied in 44 cases of bladder cancer and 10 cases of renal cell carcinoma." | 7.67 | [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma]. ( Fujioka, Y; Hirasawa, S; Ishii, Y; Ito, H; Lin, TT; Nakagami, Y; Ogawa, H; Tanaka, K; Tannawa, K; Yamada, N, 1987) |
| "To evaluate the effect of UFT, a mixture of ftorafur and uracil in a ratio of 1:4, in preventing postoperative recurrence of bladder cancer, we performed a randomized controlled study with a non-medication group as control." | 5.06 | [Prophylactic effect of UFT on the recurrence of bladder cancer]. ( Ejiri, S; Hisazumi, H; Kanda, S; Katsumi, T; Kitagawa, K; Mikawa, I; Miyagi, T; Naito, K; Nakamura, T; Saka, A, 1990) |
| "The safety of prolonged administration of UFT in which tegafur and uracil were mixed in a ratio of 1:4 in molar fraction was studied in 44 cases of bladder cancer and 10 cases of renal cell carcinoma." | 3.67 | [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma]. ( Fujioka, Y; Hirasawa, S; Ishii, Y; Ito, H; Lin, TT; Nakagami, Y; Ogawa, H; Tanaka, K; Tannawa, K; Yamada, N, 1987) |
| "In the study of bladder cancer, neither a significant difference of non-recurrent rate nor of survival rate was seen between the two groups." | 2.69 | [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group]. ( Akaza, H; Hattori, K; Ishikawa, S; Kawai, K; Kikuchi, K; Kobayashi, T; Koiso, K; Kondo, F; Manabe, F; Matsuki, K; Miyanaga, N; Noguchi, R; Shimazui, T; Suzuki, R; Takeshima, H; Tsuchiya, A; Uchida, K, 1998) |
| "To prevent postoperative recurrence a randomized prospective trial was performed on 45 patients with bladder cancers by dividing them into 2 groups given either UFT therapy alone or UFT therapy in combination with Bestatin." | 2.68 | Adjuvant therapy with 5-fluoro-1-(2-tetrahydrofuryl)-2,4 (1H,3H)-pyrimidinedione (UFT) and Bestatin in patients with transitional cell carcinoma of the bladder--comparison between UFT therapy alone and UFT therapy in combination with Bestatin. ( Koshida, K; Kunimi, K; Uchibayashi, T; Yamamoto, H, 1995) |
| "Computed tomographic scan revealed the bladder tumors and swelling of the internal iliac lymph nodes." | 2.40 | [A case of urothelial carcinoma associated with penile metastasis]. ( Horinaga, M; Ikeuchi, K; Kosugi, M, 1999) |
| "She had a history of superficial bladder tumors which were treated with transurethral resection (TURBT)." | 1.34 | [Superficial bladder cancer with lung metastasis without local invasion: a case report]. ( Ao, T; Baba, S; Hirayama, T; Irie, A; Iwabuchi, K; Iwamura, M; Kudoh, O; Matsumoto, K; Uchida, T, 2007) |
| "The diagnosis was bladder cancer (TCC, G3, T4N3M1) from detailed examination." | 1.30 | [A case of untreatable progressive bladder carcinoma effectively treated by single administration of tegafur and uracil]. ( Goto, R; Ikeuchi, T; Kai, Y; Ota, M; Yoshikawa, H, 1998) |
| " Since she complained of olfactory anesthesia at 2 months of treatment, the dosage of UFT was reduced to 2 capsules daily and the drug was withdrawn after another 2 months of treatment." | 1.28 | [Complete remission of lung metastases of bladder tumor treated by small dosage of UFT: a case report]. ( Fukuoka, H; Nomura, S; Ogawa, T; Sakanishi, S; Takeda, M, 1991) |
| "Thermotherapy combined with tegafur (FT-207) and Picibanil was performed in 13 patients with cancer of the urinary bladder." | 1.27 | [Thermotherapy for cancer of the urinary bladder in combination with tegafur suppository and picibanil--concentrations of tegafur in the serum and tissues in bladder carcinoma]. ( Arai, T; Honda, M; Kanbe, K; Kaneko, K; Maeda, S; Mukae, K; Murahashi, I; Sakuma, H; Tabata, Y; Takasaki, E, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (48.00) | 18.7374 |
| 1990's | 10 (40.00) | 18.2507 |
| 2000's | 2 (8.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichinohe, K | 1 |
| Ijima, M | 1 |
| Usami, T | 1 |
| Baba, S | 2 |
| Server Pastor, G | 1 |
| Rigabert Montiel, M | 1 |
| Bañón Pérez, V | 1 |
| Valdelvira Nadal, P | 1 |
| Cao Avellaneda, E | 1 |
| García Hernández, JA | 1 |
| Pérez Albacete, M | 1 |
| Hirayama, T | 1 |
| Matsumoto, K | 1 |
| Irie, A | 1 |
| Iwamura, M | 1 |
| Kudoh, O | 1 |
| Iwabuchi, K | 1 |
| Ao, T | 1 |
| Uchida, T | 1 |
| Mishina, T | 2 |
| Kobayashi, T | 3 |
| Maegawa, M | 2 |
| Nakao, M | 2 |
| Nakagawa, S | 2 |
| Akiyama, J | 1 |
| Sagara, Y | 1 |
| Takeda, Y | 1 |
| Watanabe, H | 1 |
| Masuda, F | 2 |
| Arai, Y | 1 |
| Tashiro, K | 1 |
| Machida, T | 1 |
| Nakamoto, T | 1 |
| Igawa, M | 1 |
| Usui, T | 1 |
| Kubota, Y | 1 |
| Hosaka, M | 1 |
| Fukushima, S | 1 |
| Kondo, I | 1 |
| Uchibayashi, T | 1 |
| Kunimi, K | 1 |
| Yamamoto, H | 1 |
| Koshida, K | 1 |
| Uchida, K | 1 |
| Takeshima, H | 1 |
| Kikuchi, K | 1 |
| Shimazui, T | 1 |
| Miyanaga, N | 1 |
| Kawai, K | 1 |
| Akaza, H | 1 |
| Tsuchiya, A | 1 |
| Noguchi, R | 1 |
| Hattori, K | 1 |
| Manabe, F | 1 |
| Matsuki, K | 1 |
| Suzuki, R | 1 |
| Ishikawa, S | 1 |
| Kondo, F | 1 |
| Koiso, K | 1 |
| Goto, R | 1 |
| Yoshikawa, H | 1 |
| Ota, M | 1 |
| Ikeuchi, T | 1 |
| Kai, Y | 1 |
| Horinaga, M | 1 |
| Kosugi, M | 1 |
| Ikeuchi, K | 1 |
| Mori, Y | 1 |
| Torii, S | 1 |
| Kawashima, Y | 1 |
| Kobari, T | 1 |
| Hosobe, T | 1 |
| Kanimoto, Y | 1 |
| Suzuki, Y | 1 |
| Miwa, Y | 1 |
| Akino, H | 1 |
| Isomatu, Y | 1 |
| Okada, K | 1 |
| Fukuoka, H | 1 |
| Takeda, M | 1 |
| Nomura, S | 1 |
| Ogawa, T | 1 |
| Sakanishi, S | 1 |
| Naito, K | 1 |
| Hisazumi, H | 1 |
| Saka, A | 1 |
| Nakamura, T | 1 |
| Kanda, S | 1 |
| Mikawa, I | 1 |
| Ejiri, S | 1 |
| Miyagi, T | 1 |
| Katsumi, T | 1 |
| Kitagawa, K | 1 |
| Nakano, E | 1 |
| Iwasaki, A | 1 |
| Seguchi, T | 1 |
| Sugao, H | 1 |
| Yoshioka, T | 1 |
| Tada, Y | 1 |
| Matsuda, M | 1 |
| Sonoda, T | 1 |
| Gelabert Mas, A | 1 |
| Arango Toro, O | 1 |
| Rosales Bordes, A | 1 |
| Coronado García, J | 1 |
| Fernández Zuazu, J | 1 |
| Yoshida, K | 2 |
| Nakame, Y | 1 |
| Horiuchi, S | 1 |
| Kaneoya, F | 1 |
| Kuroda, T | 1 |
| Tanoiri, A | 1 |
| Koizumi, M | 1 |
| Takahashi, M | 1 |
| Negishi, T | 1 |
| Saitoh, H | 1 |
| Hayashi, Y | 1 |
| Komada, S | 1 |
| Maruyama, Y | 1 |
| Hirao, Y | 2 |
| Okajima, E | 2 |
| Ohara, S | 1 |
| Ozono, S | 1 |
| Hiramatsu, T | 1 |
| Yamada, K | 1 |
| Aoyama, H | 1 |
| Hashimoto, M | 1 |
| Watanabe, S | 1 |
| Nakagami, Y | 1 |
| Lin, TT | 1 |
| Ito, H | 1 |
| Hirasawa, S | 1 |
| Tannawa, K | 1 |
| Fujioka, Y | 1 |
| Ogawa, H | 1 |
| Tanaka, K | 1 |
| Yamada, N | 1 |
| Ishii, Y | 1 |
| Sato, K | 1 |
| Hatano, T | 1 |
| Miyazato, T | 1 |
| Saito, S | 1 |
| Kashiwabara, N | 1 |
| Igarashi, M | 1 |
| Koyama, Y | 1 |
| Hayakawa, M | 1 |
| Osawa, A | 1 |
| Murahashi, I | 1 |
| Mukae, K | 1 |
| Tabata, Y | 1 |
| Sakuma, H | 1 |
| Kanbe, K | 1 |
| Arai, T | 1 |
| Kaneko, K | 1 |
| Honda, M | 1 |
| Maeda, S | 1 |
| Takasaki, E | 1 |
2 reviews available for tegafur and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Complete remission of primary retroperitoneal transitional cell carcinoma after radiotherapy and oral chemotherapy: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Combined Modalit | 2013 |
[A case of urothelial carcinoma associated with penile metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Humans; Lymphati | 1999 |
7 trials available for tegafur and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
[Oral tegafur plus mitomycin versus intravesical mitomycin alone in the prevention of recurrence in stage Ta bladder tumors].
Topics: Administration, Intravesical; Administration, Oral; Antibiotics, Antineoplastic; Antineoplastic Agen | 2003 |
Prophylactic oral UFT therapy for superficial bladder cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 1993 |
Adjuvant therapy with 5-fluoro-1-(2-tetrahydrofuryl)-2,4 (1H,3H)-pyrimidinedione (UFT) and Bestatin in patients with transitional cell carcinoma of the bladder--comparison between UFT therapy alone and UFT therapy in combination with Bestatin.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Co | 1995 |
[Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Antineop | 1998 |
[A comparative clinical trial of UFT treatment and intravesical adriamycin instillation to prevent recurrence of superficial bladder cancer].
Topics: Administration, Intravesical; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; | 1992 |
[Prophylactic effect of UFT on the recurrence of bladder cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 1990 |
Prophylactic treatment for superficial bladder cancer following transurethral resection.
Topics: Administration, Intravesical; Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Combined Mo | 1987 |
16 other studies available for tegafur and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
[Superficial bladder cancer with lung metastasis without local invasion: a case report].
Topics: Administration, Intravesical; Administration, Oral; Aged; Antineoplastic Agents; BCG Vaccine; Carcin | 2007 |
Development and clinical application of an AFC regimen (adriamycin, futraful, cytosine arabinoside) for superficial bladder tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabin | 1983 |
[Effective cases of advanced endometrial and recurrent ovarian cancers treated with oral administration of UFT].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Tra | 1984 |
[Clinical application of tegafur suppositories for bladder tumor].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Fluorouracil; Humans; Male; Mid | 1983 |
[Clinical effect of UFT on urogenital tumors].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone an | 1984 |
[Successful inhibition of bladder tumor recurrence by oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional | 1994 |
[A case of untreatable progressive bladder carcinoma effectively treated by single administration of tegafur and uracil].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Administration Sc | 1998 |
[Thymidylate synthase inhibition and concentration of 5-fluorouracil after administration of UFT in human uroepithelial carcinomas].
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto | 1991 |
[Complete remission of lung metastases of bladder tumor treated by small dosage of UFT: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Female; Humans; Lung N | 1991 |
[Case report of a complete regression of para-aortic lymph node metastasis from bladder cancer by oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional | 1989 |
[Oral cytostatic agents in the prevention of urothelial carcinoma. Our experience].
Topics: Administration, Oral; Adult; Aged; Carcinoma, Transitional Cell; Drug Eruptions; Foot Dermatoses; Ha | 1988 |
[Effect of combination chemotherapy of tegafur, adriamycin and cisplatin on patients with advanced relapsing prostatic carcinoma and advanced bladder tumor].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; | 1986 |
[Primary transitional cell carcinoma of the male urethra: report of a case].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Combined Modali | 1987 |
[Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Carcinoma, Trans | 1987 |
[Clinical studies of the treatment of bladder tumor and its effects--experience in 86 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Tr | 1988 |
[Thermotherapy for cancer of the urinary bladder in combination with tegafur suppository and picibanil--concentrations of tegafur in the serum and tissues in bladder carcinoma].
Topics: Adult; Aged; Biological Products; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Fl | 1985 |